Breast Cancer Clinical Trials

Showing 5081-5100 of 5,597 trials

Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

NCT00003412

RATIONALE: Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill breast cancer cells. PURPOSE: Phase I trial to study the effectiveness of interleukin-12 in treating women with metastatic breast cancer who have received high-dose chemotherapy and peripheral stem cell transplantation.

Breast Cancer

Beth Israel Deaconess Medical Center35 participantsStarted Jun 1998

Boston, Massachusetts, United States

COMPLETEDPhase 3

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

NCT00003013

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining surgery with chemotherapy may kill more tumor cells. It is not yet known which treatment regimen is more effective for breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of chemotherapy plus surgery in treating women who have breast cancer.

Breast Cancer

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano450 participantsStarted Oct 1996

Vienna, Austria • Ostrava-Poruba, Czechia • Tartu, Estonia +25 more locations

Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

Related Searches

Regenerative Tissue Matrix for Breast Reconstruction

Docetaxel in Treating Older Women With Metastatic Breast Cancer

Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer

Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer

Early Detection of Breast Cancer and Cervical Cancer in Women in India

A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy

Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer

Fatigue in Breast Cancer Survivors

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Acupuncture or Self-Acupuncture in Managing Cancer-Related Fatigue in Women Who Have Received Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer